HuGE Literature Finder
Records
1
-
5
The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2018 Apr 34 (2): 328-336. Bedewy Ahmed M L, Showeta Salah, Mostafa Mostafa Hasan, Kandil Lamia Sae |
Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction. Journal of biomedicine & biotechnology 2011 2011 739751. Kringen Marianne K, Haug Kari Bente Foss, Grimholt Runa M, Stormo Camilla, Narum Sigrid, Opdal Mimi S, Fosen Jan Toralf, Piehler Armin P, Johansen Per W, Seljeflot Ingebjørg, Berg Jens Petter, Brørs O |
Vitamin K epoxide reductase complex subunit 1 gene polymorphism is associated with atherothrombotic complication after drug-eluting stent implantation: 2-Center prospective cohort study. American heart journal 2009 May 157 (5): 908-12. Suh Jung-Won, Baek Sang-Hong, Park Jin-Shik, Kang Hyun-Jae, Chae In-Ho, Choi Dong-Ju, Park Hun-Jun, Kim Pum-Joon, Seung Ki-Bae, Kim Hyo-S |
Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction. Thrombosis journal 2008 6 7. Haug Kari Bente Foss, Sharikabad Mohammad N, Kringen Marianne K, Narum Sigrid, Sjaatil Stine T, Johansen Per Wiik, Kierulf Peter, Seljeflot Ingebjørg, Arnesen Harald, Brørs O |
Functional promoter polymorphism in the VKORC1 gene is no major genetic determinant for coronary heart disease in Northern Germans. Thrombosis and haemostasis 2007 Jun 97 (6): 998-1002. Watzka Matthias, Nebel Almut, El Mokhtari Nour Eddine, Ivandic Boris, Müller Jens, Schreiber Stefan, Oldenburg Johann |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 20, 2022
- Content source: